Neurology® Podcast Ten Years of Neurology® Neuroimmunology & Neuroinflammation
Jan 27, 2025
Dr. Josep Dalmau, a leader in neuroimmunology, discusses the past decade's evolution in the field. He highlights how a neuroimmunology journal has become a pivotal resource for clinical advancements. The conversation dives into AI’s potential in medical publishing and tackles complex topics like perineoplastic neurological disorders and the nuances of autoimmune epilepsy. Dalmau also clarifies GAD disorders and MOGAD, emphasizing recent breakthroughs that could transform treatment approaches for these conditions.
AI Snips
Chapters
Transcript
Episode notes
Josep Dalmau's Editor Journey
- Josep Dalmau shared his experience becoming editor of Neurology: Neuroimmunology & Neuroinflammation soon after its launch with no prior editorial experience.
- Despite initial hesitation, he found it a great decision that taught him a lot and contributed to the journal's success.
AI's Growing Role in Publishing
- AI will revolutionize many aspects of medical publishing from literature review, manuscript drafting, to post-publication impact monitoring.
- It can also detect fraudulent practices like data or figure manipulation more effectively than humans.
Updated Paraneoplastic Syndrome Criteria
- Updated diagnostic criteria now classify paraneoplastic syndromes and autoimmune encephalitis separately, recognizing overlap and differing treatment responses.
- They include antibody risk-based classification and scoring algorithms to improve diagnosis.